| abstract |
The present invention is directed to a compound of formula I which is an inhibitor of factor Xa or a pharmaceutically acceptable salt, ester or prodrug thereof. The present invention relates to intermediates used for the production of such compounds, pharmaceutical compositions comprising such compounds, methods for preventing or treating a number of conditions characterized by undesirable thrombus, and coagulation of blood samples The method of preventing this is also targeted. The present invention further includes administering a therapeutically effective amount of a compound of the present invention to a mammal, a chemical intermediate for preventing or treating a condition in the mammal characterized by an undesirable thrombus, a pharmaceutical composition, and Provide a method. |